Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury.
about
Impaired neuropathic pain and preserved acute pain in rats overexpressing voltage-gated potassium channel subunit Kv1.2 in primary afferent neuronsIncreased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain.Nerve injury-induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons.Demethylating drugs as novel analgesics for cancer pain.μ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in miceInjury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodentsAcute morphine induces matrix metalloproteinase-9 up-regulation in primary sensory neurons to mask opioid-induced analgesia in mice.Increasing intensity of TENS prevents analgesic tolerance in rats.Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive ActivitymTOR and its downstream pathway are activated in the dorsal root ganglion and spinal cord after peripheral inflammation, but not after nerve injuryDorsal root ganglion transcriptome analysis following peripheral nerve injury in mice.Tet1-dependent epigenetic modification of BDNF expression in dorsal horn neurons mediates neuropathic pain in rats.G9a inhibits CREB-triggered expression of mu opioid receptor in primary sensory neurons following peripheral nerve injury.Temporal changes in MrgC expression after spinal nerve injury.μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.Chronic pain: emerging evidence for the involvement of epigenetics.Transmission pathways and mediators as the basis for clinical pharmacology of pain.How can precision medicine be applied to temporomandibular disorders and its comorbidities?Modulating pain in the periphery: gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010.Contribution of the Suppressor of Variegation 3-9 Homolog 1 in Dorsal Root Ganglia and Spinal Cord Dorsal Horn to Nerve Injury-induced Nociceptive HypersensitivityDNMT3a methylation in neuropathic pain.Spinal cord stimulation reduces hypersensitivity through activation of opioid receptors in a frequency-dependent manner.OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain.Estrogens synthesized and acting within a spinal oligomer suppress spinal endomorphin 2 antinociception: ebb and flow over the rat reproductive cycle.N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression.
P2860
Q28568519-6BACCDA9-7763-44F2-8166-17391CA10493Q34062512-5CF08EEA-399F-4493-9F6B-27B298FEE494Q34680966-1CBE4399-67F8-49AE-BE3E-1CCF97182A74Q34959705-3352BA3C-9436-41D3-BA29-CBA1B2B1BBC4Q35053136-69152101-6172-4A88-A7C7-BFE5E99282A6Q35155806-D96FB2F3-8394-4CFB-9028-51B7A6DCA10BQ35963214-B5430707-39EC-471F-A71A-BC6AC9035EE3Q36290021-B4805618-E9FC-47DF-8D24-7F2BDAC8B599Q36431999-52C525E4-C3EA-4C6B-A8F0-F8D5B9360CADQ36843926-8E7555F3-3117-447A-94AC-FDC59E0C0051Q37114733-DA306E2B-7A38-4680-9F4B-D98822652CA9Q37421849-099801C5-69AE-42E4-8388-D96061BB7967Q37495693-C99B423D-4C3D-4927-8209-6AFB49AC869AQ37622877-759287D6-DBEA-4F2D-AB59-D880D8A62A3BQ37721910-8386C533-EDE8-40F2-876A-D3CFA902E77AQ37983159-3978F39C-AE5E-4562-AF4D-6D659A5A9D4FQ38870522-CC095476-8000-4E52-A6DF-F9EE69295FD6Q39456657-81C59C1D-7750-4B08-BF58-6634FC68CD7BQ39673255-8779A996-E99C-4376-83CE-413A01F15E8BQ41631815-A300E3C7-B4E9-4BB5-83C2-EAF635636135Q42731697-85ADC4D0-2CD7-4F76-832D-ACDF6C095335Q44336420-F0DD0729-2E6B-4F95-85BC-5CB4DEE51CC6Q44345268-7696D540-5852-4E73-AB15-AEA5B0E9C897Q47566382-CF56C0B6-99D9-4341-B8D8-2A2B550ACA70Q50118856-686715F8-02A7-4A09-9984-2A03CBEB3907Q55006112-9A5882A4-C0DA-44CE-9D52-72CD06334BF1
P2860
Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dynamic temporal and spatial r ...... following spinal nerve injury.
@ast
Dynamic temporal and spatial r ...... following spinal nerve injury.
@en
type
label
Dynamic temporal and spatial r ...... following spinal nerve injury.
@ast
Dynamic temporal and spatial r ...... following spinal nerve injury.
@en
prefLabel
Dynamic temporal and spatial r ...... following spinal nerve injury.
@ast
Dynamic temporal and spatial r ...... following spinal nerve injury.
@en
P2093
P2860
P1476
Dynamic temporal and spatial r ...... following spinal nerve injury.
@en
P2093
Chun-Yi Lee
Federico M Perez
Janet L Fisher
Sarah M Sweitzer
Srinivasa N Raja
Xiaowei Guan
Xiuli Zhao
Yuan-Xiang Tao
P2860
P304
P356
10.1016/J.EJPAIN.2010.11.018
P577
2011-02-09T00:00:00Z